找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: High-Risk IV Medications in Special Patient Populations; Sandra Kane-Gill,Joseph Dasta Book 2011 Springer-Verlag London Limited 2011 High

[復(fù)制鏈接]
查看: 17084|回復(fù): 35
樓主
發(fā)表于 2025-3-21 20:01:48 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱High-Risk IV Medications in Special Patient Populations
編輯Sandra Kane-Gill,Joseph Dasta
視頻videohttp://file.papertrans.cn/427/426747/426747.mp4
概述The Institute for Safe Medication Practices has developed a list of high-alert medications which are medications at a heightened risk for patient harm when used in error.No book has been published on
圖書封面Titlebook: High-Risk IV Medications in Special Patient Populations;  Sandra Kane-Gill,Joseph Dasta Book 2011 Springer-Verlag London Limited 2011 High
描述Critical Care Clinicians can use general drug references (Micomedex, Lexicomp) for data on dosing of high-alert medications in special patient populations but these references are not available to all healthcare clinicians, they are expensive and they are not specific to high-alert medications or critically ill patients. Doctors, nurses and pharmacists in the hospital setting will benefit from having one resource with all of this information. The purpose of this reference manual would be to guide critical care clinicians on dosing of high-alert medications in special patient populations. The most important feature of the book will be a summary of primary literature using tables when possible. This will be useful to readers because currently a reference book does not exist that guides clinicians in these difficult dosing decisions.
出版日期Book 2011
關(guān)鍵詞High Risk; Medication; Special Patient
版次1
doihttps://doi.org/10.1007/978-0-85729-606-1
isbn_softcover978-1-4471-5868-4
isbn_ebook978-0-85729-606-1
copyrightSpringer-Verlag London Limited 2011
The information of publication is updating

書目名稱High-Risk IV Medications in Special Patient Populations影響因子(影響力)




書目名稱High-Risk IV Medications in Special Patient Populations影響因子(影響力)學(xué)科排名




書目名稱High-Risk IV Medications in Special Patient Populations網(wǎng)絡(luò)公開度




書目名稱High-Risk IV Medications in Special Patient Populations網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱High-Risk IV Medications in Special Patient Populations被引頻次




書目名稱High-Risk IV Medications in Special Patient Populations被引頻次學(xué)科排名




書目名稱High-Risk IV Medications in Special Patient Populations年度引用




書目名稱High-Risk IV Medications in Special Patient Populations年度引用學(xué)科排名




書目名稱High-Risk IV Medications in Special Patient Populations讀者反饋




書目名稱High-Risk IV Medications in Special Patient Populations讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:06:37 | 只看該作者
板凳
發(fā)表于 2025-3-22 03:08:14 | 只看該作者
地板
發(fā)表于 2025-3-22 06:53:51 | 只看該作者
Thrombolytics/Anticoagulants,f medical intervention, and 1.5% of patients experience prolonged hospitalization due to anticoagulant effects.. The most common types of medication errors regarding anticoagulant use are omission (29%), improper dose/quantity (27.9%), and prescribing (14.5%) errors..
5#
發(fā)表于 2025-3-22 12:25:21 | 只看該作者
6#
發(fā)表于 2025-3-22 15:33:01 | 只看該作者
7#
發(fā)表于 2025-3-22 17:57:53 | 只看該作者
Sandra Kane-Gill,Joseph DastaThe Institute for Safe Medication Practices has developed a list of high-alert medications which are medications at a heightened risk for patient harm when used in error.No book has been published on
8#
發(fā)表于 2025-3-22 23:33:09 | 只看該作者
http://image.papertrans.cn/h/image/426747.jpg
9#
發(fā)表于 2025-3-23 05:11:47 | 只看該作者
10#
發(fā)表于 2025-3-23 07:01:53 | 只看該作者
James C. Coons,Sandeep Devabhakthunin, Litzen, B?nder, Zwirn. In der Abteilung F?rberei wurde unter Beteiligung der direkt betroffenen Fachkr?fte ein Computersystem zur Farbdatenverarbeitung eingeführt. Traditionell verrichten die F?rber dieser Abteilung eine vorwiegend handwerkliche T?tigkeit, in der Geschick, Wissen um Rezepturen un
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 14:09
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
新安县| 唐海县| 阿勒泰市| 定西市| 于田县| 永靖县| 自治县| 沙坪坝区| 凤山县| 呼玛县| 太仓市| 云林县| 黎平县| 阜城县| 永善县| 卢湾区| 富源县| 正定县| 南雄市| 临潭县| 漳平市| 洛浦县| 融水| 滦平县| 抚州市| 亚东县| 山东| 凤阳县| 遂宁市| 大竹县| 黄陵县| 大港区| 阳信县| 竹山县| 鹤峰县| 陆河县| 文昌市| 丰都县| 潼南县| 永兴县| 汕头市|